Saturday, June 12, 2021

BeiGene Presents Long-Term Efficacy and Safety Results from Three Pivotal Trials...

0
CAMBRIDGE, Mass. & BEIJING-- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced...

Pharma

Biotech

Biotech and Pharma Labs Performing Endpoint PCR Can Reduce Amplification Time to 15 Minutes

HAMBURG, Germany & MADISON, Wis.-- Biotech and pharma labs performing endpoint polymerase chain reaction (PCR) can amplify samples in as little as 15 minutes...

Waters Sets New Standard in High Resolution Mass Spectrometry with SELECT SERIES Multi Reflecting Time-of-Flight Platform

MILFORD, Mass.-- Waters Corporation (NYSE:WAT) today introduced the Waters™ SELECT SERIES™ MRT, a high-resolution mass spectrometer that combines Multi Reflecting Time-of-Flight (MRT) technology with...

Bruker Launches timsTOF trueSCP for Unbiased Single Cell 4D-Proteomics and Next-gen timsTOF Pro 2 with Unprecedented Proteomic Depth

BILLERICA, Mass.-- At Bruker’s virtual 4D-Proteomics™ eXceed Symposium, Bruker Corporation (Nasdaq: BRKR) today announced the launch of two new timsTOF instruments. They further advance...

Waters Introduces the SARS-CoV-2 LC-MS Kit (RUO) to Advance Clinical Research of Infectious Diseases

MILFORD, Mass.-- Waters Corporation (NYSE:WAT) today introduced a new RUO LC-MS test method to advance critical infectious disease research. Waters™ SARS-CoV-2 LC-MS Kit (RUO)...

ruker’s Molecular Phenomics Research Tools Enable New Insights into ‘Long COVID’ and Post-Acute Metabolic Abnormalities

PERTH, Australia-- A clinical research collaboration on COVID-19 pheno-conversion and subsequent pheno-reversion has discovered transient and persistent systemic changes of the molecular signatures in...

New England Cancer Specialists Adopt Deep Lens’ Clinical Trial Matching Solution VIPER™ to Expand Clinical Trial Offering

COLUMBUS, Ohio & SCARBOROUGH, Maine-- Deep Lens and New England Cancer Specialists (NECS) today announced that they have entered into a strategic collaboration to...

Finance

Public Health

COVID-19 Statistics

United States
614,955
Total deaths
Updated on June 12, 2021 11:15 pm
- Advertisement -

Medtech

Real Estate

GMH Communities Capitalizes on Growing Life Sciences Sector With New ‘Innovative Living’ Vertical, Announces First Projects

NEWTOWN SQUARE, Pa.-- GMH Communities ("GMH") announced today the launch of a completely new vertical called “Innovative Living.” Innovative Living represents the collision of...

Harrison Street Announces $1.6 Billion in Transformational Medical Office and Senior Housing Transactions

CHICAGO-- Harrison Street, one of the leading investment management firms exclusively focused on alternative real assets, today announced it has entered into a series...

Boston Properties Builds on Its Growing Life Sciences Portfolio, Acquires Lab Properties in Waltham, Massachusetts

BOSTON-- Boston Properties, Inc. (NYSE: BXP), the largest publicly traded developer, owner, and manager of Class A office properties in the United States, announced...

Life Sciences

Entegris Expands Life Sciences Production Capacity and Capabilities

BILLERICA, Mass.-- Entegris, Inc. (NASDAQ: ENTG), a world-class supplier of advanced materials and process solutions for the semiconductor and other high-technology industries, today announced...

Harvard Licenses Technology to Obatala Sciences to Advance Discovery in Obesity, Diabetes, and Cancer

CAMBRIDGE, Mass. & NEW ORLEANS-- Harvard University has granted an exclusive license to biotechnology company Obatala Sciences to commercialize innovations that enable the study...

Agilent Presents Thought Leader Award to Professor Chris Elliott

SANTA CLARA, Calif.-- Agilent Technologies Inc. (NYSE: A) today announced that Chris Elliott has received an Agilent Thought Leader Award. Dr. Elliott is Professor...

CUBIO Innovation Center and CreaGen Enter Into Partnership Agreement

HOUSTON & BOSTON-- The CUBIO Innovation Center of Houston, Texas has entered into a partnership agreement with CreaGen, Inc., based outside of Boston in...

The Bristol Myers Squibb Foundation Announces First Global Cancer Disparities Grants in Brazil

New York-- The Bristol Myers Squibb Foundation has launched a new initiative in Brazil, awarding four grants aimed at improving the delivery of high-quality...
- Advertisement -

Today's Headlines

Advertisment

LATEST ARTICLES

BeiGene Presents Long-Term Efficacy and Safety Results from Three Pivotal Trials of BRUKINSA

CAMBRIDGE, Mass. & BEIJING-- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced...

U.S. Food and Drug Administration Approves New Formulation of Epclusa®, Expanding Pediatric Indication to Treat Children Ages 3 and Older With Chronic Hepatitis C

FOSTER CITY, Calif.-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that the U.S. Food and Drug Administration (FDA) has approved an expansion of the...

STORY3 Capital Partners Completes Structured Growth Equity Investment in Renew Anchored Dentures

LOS ANGELES-- STORY3 Capital Partners, LLC (“STORY3”), a capital solutions provider founded by veteran deal maker Peter Comisar that is focused exclusively on the...

ElevateBio Announces Margo Roberts, Ph.D. Joins as Scientific Advisor for Company’s Immunotherapy Platform Expansion

CAMBRIDGE, Mass.-- ElevateBio, a cell and gene therapy technology company focused on powering transformative cell and gene therapies, today announced that Margo Roberts, Ph.D.,...

Owl Peak Labs Closes Seed Round

CHARLOTTESVILLE, Va.-- Owl Peak Labs, a life sciences company that develops new screening solutions to detect colorectal cancer, announced today the fully subscribed closure...

Icosavax Appoints Thomas J. Russo Chief Financial Officer

SEATTLE-- Icosavax, Inc. today announced the appointment of Thomas J. Russo as Chief Financial Officer. Mr. Russo brings more than 25 years of diverse...

Anji Pharma Launches Phase 3 Trial for ANJ900 to Treat Type 2 Diabetes Patients with Kidney Disease

CAMBRIDGE, Mass. & SHANGHAI-- Anji Pharma (“Anji”) has initiated a pivotal trial of ANJ900 (delayed-release metformin) in patients with Type 2 diabetes (T2D), including...

Kojin Therapeutics Launches with $60 Million Series A to Develop New Category of Drugs Based on Cell State Biology

CAMBRIDGE, Mass.-- Kojin Therapeutics Inc., the leading company developing new targeted therapeutics based on cell state and ferroptosis biology, today launched with a $60...

SARS-CoV-2 Antibody Test Developed by Promega Receives CE Mark

MADISON, Wis.-- A SARS-CoV-2 antibody test developed by Promega Corporation, the Lumit™ Dx SARS-CoV-2 Immunoassay, has received CE marking and is now available in...

Datavant and Ciox Health Announce Merger, Creating the Largest Neutral and Secure Health Data Ecosystem

SAN FRANCISCO & ALPHARETTA, Ga.-- Datavant, the leader in helping healthcare organizations securely connect their data, and Ciox Health, the leader in clinical data...

Most Popular

Recent Comments